Ildong Pharmaceutical Co., Ltd.
Ildong Pharmaceutical Co., Ltd. (KRX: 249420) is trading at ₩14,020.00, about ₹1,012 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 5.33% today. Ildong Pharmaceutical is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩14,020.00
Today's high
₩14,740.00
52 week low
₩11,250.00
52 week high
₩45,050.00
249420 opened at ₩14,680.00, closed previously at ₩14,810.00, and has traded between ₩11,250.00 and ₩45,050.00 over the past 52 weeks.
About
Ildong Pharmaceutical Co., Ltd., established in 1941 and headquartered in Seoul, South Korea, is a company dedicated to the development, production, and distribution of a wide array of pharmaceutical products. Its extensive portfolio includes various medications such as anti-diarrheal agents, antibiotics, antifungals, antivirals, antihistamines, anticancer drugs, NSAIDs, and pain relievers, along with essential vitamins, minerals, and nutritional supplements. The company also produces treatments for numerous bodily systems, including cardiovascular, central nervous, dental, endocrine, gastrointestinal, respiratory, topical, and urogenital health, as well as those for blood circulation. Beyond pharmaceuticals, Ildong offers raw material drugs, health foods, cosmetics, and specialized medical devices, such as scar treatment products. Their range also extends to unique treatments for conditions like osteoarthritis, wound care, artificial tears, and feminine hygiene products. In addition to its product offerings, the company manages licenses and provides contract manufacturing services. With a global reach, Ildong Pharmaceutical exports its products to approximately 20 countries. Furthermore, the company has entered into a strategic collaboration with Evotec SE, leveraging Evotec's INDiGO platform to accelerate the development of its proprietary projects.
Key statistics
Avg. volume
250.38K
Market cap
₩441.74B
P/E Ratio
9.89
Price-to-sales ratio
0.76
Enterprise value
₩1.24T
Free cash flow yield
0.46%
Debt-to-equity ratio
0.55
Return on equity
11.23%
ROIC
2.79%
Beta
0.84
Dividend yield
1.43%
Last dividend
₩200.00
Financial overview
Revenue
₩566.93B
Earnings per share
₩942.08
Free cash flow
₩5.30B
Net profit margin
7.49%
Gross margin
38.39%
EBITDA
₩39.90B
Revenue growth
-7.81%
Similar securities
This is not an investment recommendation
Ildong Pharmaceutical for Indian investors
Ildong Pharmaceutical is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Ildong Pharmaceutical for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Ildong Pharmaceutical’s current yield is 1.43%.Dividend tax explained
FAQs
Can I buy Ildong Pharmaceutical on Paasa?
Ildong Pharmaceutical (249420) has been listed on the Korea Exchange since 2016, in the Drug Manufacturers - Specialty & Generic industry. Ildong Pharmaceutical is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Ildong Pharmaceutical share cost in rupees?
One Ildong Pharmaceutical share is ₩14,020.00 — about ₹1,012 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Ildong Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Ildong Pharmaceutical shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Ildong Pharmaceutical price.
Does Ildong Pharmaceutical pay a dividend, and how is it taxed in India?
Yes. Ildong Pharmaceutical pays a dividend and the current yield is 1.43%; the last declared dividend was ₩200.00 per share, about ₹14.43. Dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Ildong Pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Ildong Pharmaceutical?
Yes. Ildong Pharmaceutical is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.